Exxon stock price: XOM closes higher into the long weekend — what investors watch next
18 January 2026
1 min read

Exxon stock price: XOM closes higher into the long weekend — what investors watch next

New York, Jan 18, 2026, 04:53 EST — Market closed

  • Exxon Mobil shares closed up 0.6% on Friday, outperforming the nearly flat broader market.
  • Crude prices climbed ahead of the U.S. holiday break, leaving energy shares jittery over the latest headlines.
  • Trading picks up Tuesday, with Exxon’s quarterly earnings later this month set to be a crucial indicator.

Exxon Mobil’s shares closed Friday up 0.6% at $129.89, having reached a session peak of $130.15 earlier in the day. With U.S. markets closed over the weekend, this will be the final price investors see until trading resumes.

The New York Stock Exchange will be closed Monday in observance of Martin Luther King Jr. Day, extending the break for U.S. equity traders. Trading resumes Tuesday. 1

Oil showed little relief for traders. Brent crude, the global benchmark, closed at $64.13 a barrel on Friday, climbing 0.6%. U.S. West Texas Intermediate (WTI) finished at $59.44, up 0.4%. Some investors stepped in to cover short positions ahead of the three-day weekend, avoiding the risk of being caught on the wrong side. “Buying today seems to be people not wanting to be caught short over the long weekend,” said Phil Flynn, senior analyst at Price Futures Group. Priyanka Sachdeva, an analyst at Phillip Nova, described oil as “range-bound,” noting Brent was “broadly hovering between $57 and $67.” 2

Chevron inched higher by 0.1% on Friday, whereas Valero Energy slipped 0.6%, MarketWatch data shows. 3

Disruptions in the Black Sea are starting to impact physical crude prices. Exxon, which holds a stake in the Caspian Pipeline Consortium, lowered its asking price on a CPC Blend cargo multiple times before pulling the offer after failing to secure a buyer, Reuters reported. CPC Blend, a Kazakhstan export grade, flows through a pipeline that represents about 1.5% of global oil supply, according to Reuters. 4

Wall Street wrapped up Friday almost unchanged. Anthony Saglimbene, chief market strategist at Ameriprise Financial, noted, “To finish the week around flat with the S&P 500 still within spitting distance of 7,000 — most investors will take that as a win.” 5

Exxon shareholders face a straightforward yet challenging short-term play: oil prices lead, and the stock tends to trail. Geopolitical news over the weekend often triggers a reset when markets open Tuesday, particularly after a long weekend that tightens positions.

The flip side is clear: if tensions ease or worries over supply ease up, crude prices could drop sharply. Energy stocks would likely retreat quickly, especially if the wider market shifts into a defensive mode.

Exxon’s next major event is the Q4 2025 earnings report, set for Friday, Jan. 30. The company will hold a conference call that same morning, according to their announcement. 6

Stock Market Today

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

7 February 2026
MARA shares jumped 22.4% to $8.24 Friday, trading higher after hours, as the company moved $87 million in bitcoin to major custodians. About 82.4 million MARA shares changed hands. Bitcoin hovered near $68,928 Saturday. A MARA filing showed its general counsel had shares withheld for taxes on vested stock units, not an open market sale.
Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

7 February 2026
Apple shares closed up 0.8% at $278.12 Friday, then slipped 0.3% after hours. A global DRAM shortage is raising component costs, putting pressure on Apple’s pricing ahead of its Feb. 24 shareholder meeting. CEO Tim Cook said memory prices will rise “sharply” but gave no details on possible iPhone price hikes. Investors await signals before next week’s U.S. inflation data.
Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
JPMorgan stock braces for Tuesday open after Trump lawsuit threat and Dimon Fed-chair denial
Previous Story

JPMorgan stock braces for Tuesday open after Trump lawsuit threat and Dimon Fed-chair denial

MercadoLibre stock slipped Friday — what MELI investors are watching after the long weekend
Next Story

MercadoLibre stock slipped Friday — what MELI investors are watching after the long weekend

Go toTop